No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Bone Marrow / pathology
-
Carrier Proteins / genetics*
-
Clonal Evolution / drug effects
-
Clonal Evolution / genetics*
-
Disease Progression
-
Gene Frequency*
-
Humans
-
Leukemia, Neutrophilic, Chronic / drug therapy*
-
Leukemia, Neutrophilic, Chronic / genetics*
-
Leukemia, Neutrophilic, Chronic / pathology
-
Leukocyte Count
-
Mutation*
-
Nitriles
-
Nuclear Proteins / genetics*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrazoles / pharmacology
-
Pyrazoles / therapeutic use*
-
Pyrimidines
-
Receptors, Colony-Stimulating Factor / genetics*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
CSF3R protein, human
-
Carrier Proteins
-
Nitriles
-
Nuclear Proteins
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyrimidines
-
Receptors, Colony-Stimulating Factor
-
SETBP1 protein, human
-
ruxolitinib